Ocular immune privilege and ocular melanoma: Parallel universes or immunological plagiarism?

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Evidence of immune privilege in the eye was recorded almost 140 years ago, yet interest in immune privilege languished for almost a century. However, the past 35 years have witnessed a plethora of research and a rekindled interest in the mechanisms responsible for immune privilege in the anterior chamber of the eye. This research has demonstrated that multiple anatomical, structural, physiological, and immunoregulatory processes contribute to immune privilege and remind us of the enormous complexity of this phenomenon. It is widely accepted that immune privilege is an adaptation for reducing the risk of immunemediated inflammation in organs such as the eye and brain whose tissues have a limited capacity to regenerate. Recent findings suggest that immune privilege also occurs in sites where stem cells reside and raise the possibility that immune privilege is also designed to prevent the unwitting elimination of stem cells by immune-mediated inflammation at these sites. Uveal melanoma arises within the eye and as such, benefits from ocular immune privilege. A significant body of research reveals an intriguing parallel between the mechanisms that contribute to immune privilege in the eye and those strategies used by uveal melanoma cells to evade immune elimination once they have disseminated from the eye and establish metastatic foci in the liver. Uveal melanoma metastases seem to have "plagiarized" the blueprints used for ocular immune privilege to create "ad hoc immune privileged sites" in the liver.

Original languageEnglish (US)
Article numberArticle 148
JournalFrontiers in Immunology
Volume3
Issue numberJUN
DOIs
StatePublished - 2012

Fingerprint

Plagiarism
Melanoma
Stem Cells
Research
Physiological Phenomena
Inflammation
Liver
Anterior Chamber
Neoplasm Metastasis

Keywords

  • Anterior chamber
  • Eye
  • Immune privilege
  • Stem cells
  • Uveal melanoma

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

Ocular immune privilege and ocular melanoma : Parallel universes or immunological plagiarism? / Niederkorn, Jerry Y.

In: Frontiers in Immunology, Vol. 3, No. JUN, Article 148, 2012.

Research output: Contribution to journalArticle

@article{7fe5456762c946eaac8abfdb90ed8108,
title = "Ocular immune privilege and ocular melanoma: Parallel universes or immunological plagiarism?",
abstract = "Evidence of immune privilege in the eye was recorded almost 140 years ago, yet interest in immune privilege languished for almost a century. However, the past 35 years have witnessed a plethora of research and a rekindled interest in the mechanisms responsible for immune privilege in the anterior chamber of the eye. This research has demonstrated that multiple anatomical, structural, physiological, and immunoregulatory processes contribute to immune privilege and remind us of the enormous complexity of this phenomenon. It is widely accepted that immune privilege is an adaptation for reducing the risk of immunemediated inflammation in organs such as the eye and brain whose tissues have a limited capacity to regenerate. Recent findings suggest that immune privilege also occurs in sites where stem cells reside and raise the possibility that immune privilege is also designed to prevent the unwitting elimination of stem cells by immune-mediated inflammation at these sites. Uveal melanoma arises within the eye and as such, benefits from ocular immune privilege. A significant body of research reveals an intriguing parallel between the mechanisms that contribute to immune privilege in the eye and those strategies used by uveal melanoma cells to evade immune elimination once they have disseminated from the eye and establish metastatic foci in the liver. Uveal melanoma metastases seem to have {"}plagiarized{"} the blueprints used for ocular immune privilege to create {"}ad hoc immune privileged sites{"} in the liver.",
keywords = "Anterior chamber, Eye, Immune privilege, Stem cells, Uveal melanoma",
author = "Niederkorn, {Jerry Y.}",
year = "2012",
doi = "10.3389/fimmu.2012.00148",
language = "English (US)",
volume = "3",
journal = "Frontiers in Immunology",
issn = "1664-3224",
publisher = "Frontiers Media S. A.",
number = "JUN",

}

TY - JOUR

T1 - Ocular immune privilege and ocular melanoma

T2 - Parallel universes or immunological plagiarism?

AU - Niederkorn, Jerry Y.

PY - 2012

Y1 - 2012

N2 - Evidence of immune privilege in the eye was recorded almost 140 years ago, yet interest in immune privilege languished for almost a century. However, the past 35 years have witnessed a plethora of research and a rekindled interest in the mechanisms responsible for immune privilege in the anterior chamber of the eye. This research has demonstrated that multiple anatomical, structural, physiological, and immunoregulatory processes contribute to immune privilege and remind us of the enormous complexity of this phenomenon. It is widely accepted that immune privilege is an adaptation for reducing the risk of immunemediated inflammation in organs such as the eye and brain whose tissues have a limited capacity to regenerate. Recent findings suggest that immune privilege also occurs in sites where stem cells reside and raise the possibility that immune privilege is also designed to prevent the unwitting elimination of stem cells by immune-mediated inflammation at these sites. Uveal melanoma arises within the eye and as such, benefits from ocular immune privilege. A significant body of research reveals an intriguing parallel between the mechanisms that contribute to immune privilege in the eye and those strategies used by uveal melanoma cells to evade immune elimination once they have disseminated from the eye and establish metastatic foci in the liver. Uveal melanoma metastases seem to have "plagiarized" the blueprints used for ocular immune privilege to create "ad hoc immune privileged sites" in the liver.

AB - Evidence of immune privilege in the eye was recorded almost 140 years ago, yet interest in immune privilege languished for almost a century. However, the past 35 years have witnessed a plethora of research and a rekindled interest in the mechanisms responsible for immune privilege in the anterior chamber of the eye. This research has demonstrated that multiple anatomical, structural, physiological, and immunoregulatory processes contribute to immune privilege and remind us of the enormous complexity of this phenomenon. It is widely accepted that immune privilege is an adaptation for reducing the risk of immunemediated inflammation in organs such as the eye and brain whose tissues have a limited capacity to regenerate. Recent findings suggest that immune privilege also occurs in sites where stem cells reside and raise the possibility that immune privilege is also designed to prevent the unwitting elimination of stem cells by immune-mediated inflammation at these sites. Uveal melanoma arises within the eye and as such, benefits from ocular immune privilege. A significant body of research reveals an intriguing parallel between the mechanisms that contribute to immune privilege in the eye and those strategies used by uveal melanoma cells to evade immune elimination once they have disseminated from the eye and establish metastatic foci in the liver. Uveal melanoma metastases seem to have "plagiarized" the blueprints used for ocular immune privilege to create "ad hoc immune privileged sites" in the liver.

KW - Anterior chamber

KW - Eye

KW - Immune privilege

KW - Stem cells

KW - Uveal melanoma

UR - http://www.scopus.com/inward/record.url?scp=84873724917&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873724917&partnerID=8YFLogxK

U2 - 10.3389/fimmu.2012.00148

DO - 10.3389/fimmu.2012.00148

M3 - Article

C2 - 22707951

AN - SCOPUS:84873724917

VL - 3

JO - Frontiers in Immunology

JF - Frontiers in Immunology

SN - 1664-3224

IS - JUN

M1 - Article 148

ER -